“… 15 Standardized whole blood stimulation technologies have been developed to overcome these limitations and have enabled the identification of stimulus induced differences in other cohorts and disease states that would otherwise have been undetectable. 16 , 17 We proposed that these cutting edge whole blood stimulation technologies would uncover additional mechanisms of innate resistance against HCV.…”